Connection

Therese Killeen to Adult

Back to Details
This is a "connection" page, showing publications Therese Killeen has written about Adult.
Therese Killeen
Connection Strength
0.606
Adult
  1. Exploring the relationship between eating disorder symptoms and substance use severity in women with comorbid PTSD and substance use disorders. Am J Drug Alcohol Abuse. 2015; 41(6):547-52.
    View in: PubMed
    Score: 0.036
  2. Menopause negatively impacts sexual lives of middle-aged Iranian women: a cross-sectional study. J Sex Marital Ther. 2014; 40(6):552-60.
    View in: PubMed
    Score: 0.032
  3. Assessment and treatment of co-occurring eating disorders in privately funded addiction treatment programs. Am J Addict. 2011 May-Jun; 20(3):205-11.
    View in: PubMed
    Score: 0.026
  4. Adverse events in an integrated trauma-focused intervention for women in community substance abuse treatment. J Subst Abuse Treat. 2008 Oct; 35(3):304-11.
    View in: PubMed
    Score: 0.021
  5. Effectiveness of motivational incentives in stimulant abusing outpatients with different treatment histories. Am J Drug Alcohol Abuse. 2007; 33(1):129-37.
    View in: PubMed
    Score: 0.020
  6. Effectiveness of naltrexone in a community treatment program. Alcohol Clin Exp Res. 2004 Nov; 28(11):1710-7.
    View in: PubMed
    Score: 0.017
  7. Comparison of self-report versus agency records of service utilization in a community sample of individuals with alcohol use disorders. Drug Alcohol Depend. 2004 Feb 07; 73(2):141-7.
    View in: PubMed
    Score: 0.016
  8. Project Harmony: A Meta-Analysis With Individual Patient Data on Behavioral and Pharmacologic Trials for Comorbid Posttraumatic Stress and Alcohol or Other Drug Use Disorders. Am J Psychiatry. 2023 02 01; 180(2):155-166.
    View in: PubMed
    Score: 0.015
  9. The effect of auricular acupuncture on psychophysiological measures of cocaine craving. Issues Ment Health Nurs. 2002 Jul-Aug; 23(5):445-59.
    View in: PubMed
    Score: 0.014
  10. Putting the Patient Back in Clinical Significance: Moderated Nonlinear Factor Analysis for Estimating Clinically Significant Change in Treatment for Posttraumatic Stress Disorder. J Trauma Stress. 2021 04; 34(2):454-466.
    View in: PubMed
    Score: 0.013
  11. Measurement nonequivalence of the Clinician-Administered PTSD Scale by race/ethnicity: Implications for quantifying posttraumatic stress disorder severity. Psychol Assess. 2020 Nov; 32(11):1015-1027.
    View in: PubMed
    Score: 0.013
  12. Parental stress and child behavioral outcomes following substance abuse residential treatment. Follow-up at 6 and 12 months. J Subst Abuse Treat. 2000 Jul; 19(1):23-9.
    View in: PubMed
    Score: 0.013
  13. N-acetylcysteine for the treatment of comorbid alcohol use disorder and posttraumatic stress disorder: Design and methodology of a randomized clinical trial. Contemp Clin Trials. 2020 04; 91:105961.
    View in: PubMed
    Score: 0.012
  14. Skin conductance hypo-responding in recently abstinent cocaine dependent inpatients. Am J Addict. 2000; 9(2):154-62.
    View in: PubMed
    Score: 0.012
  15. Estimation of equable scale scores and treatment outcomes from patient- and clinician-reported PTSD measures using item response theory calibration. Psychol Assess. 2020 Apr; 32(4):321-335.
    View in: PubMed
    Score: 0.012
  16. Does trauma-focused exposure therapy exacerbate symptoms among patients with comorbid PTSD and substance use disorders? Behav Cogn Psychother. 2020 Jan; 48(1):38-53.
    View in: PubMed
    Score: 0.012
  17. Veterans with PTSD and comorbid substance use disorders: Does single versus poly-substance use disorder affect treatment outcomes? Drug Alcohol Depend. 2019 06 01; 199:70-75.
    View in: PubMed
    Score: 0.012
  18. Heterogeneity of treatment dropout: PTSD, depression, and alcohol use disorder reductions in PTSD and AUD/SUD treatment noncompleters. Clin Psychol Psychother. 2019 Mar; 26(2):218-226.
    View in: PubMed
    Score: 0.011
  19. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: A randomized clinical trial in military veterans. Addict Behav. 2019 03; 90:369-377.
    View in: PubMed
    Score: 0.011
  20. Substance use disorders and PTSD: Examining substance use, PTSD symptoms, and dropout following imaginal exposure. Addict Behav. 2019 03; 90:35-39.
    View in: PubMed
    Score: 0.011
  21. Prevalence of obesity for opioid- and stimulant-dependent participants in substance use treatment clinical trials. Drug Alcohol Depend. 2018 09 01; 190:255-262.
    View in: PubMed
    Score: 0.011
  22. Rationale, design, and implementation of a clinical trial of a mindfulness-based relapse prevention protocol for the treatment of women with comorbid post traumatic stress disorder and substance use disorder. Contemp Clin Trials. 2017 10; 61:108-114.
    View in: PubMed
    Score: 0.010
  23. The Role of Relationship Adjustment in an Integrated Individual Treatment for PTSD and Substance Use Disorders Among Veterans: An Exploratory Study. J Dual Diagn. 2017 Jul-Sep; 13(3):213-218.
    View in: PubMed
    Score: 0.010
  24. Concurrent Treatment with Prolonged Exposure for Co-Occurring Full or Subthreshold Posttraumatic Stress Disorder and Substance Use Disorders: A Randomized Clinical Trial. Psychother Psychosom. 2017; 86(3):150-161.
    View in: PubMed
    Score: 0.010
  25. Integrated, exposure-based treatment for PTSD and comorbid substance use disorders: Predictors of treatment dropout. Addict Behav. 2017 10; 73:30-35.
    View in: PubMed
    Score: 0.010
  26. Integrated Treatment of PTSD and Substance Use Disorders: Examination of Imaginal Exposure Length. J Trauma Stress. 2017 04; 30(2):166-172.
    View in: PubMed
    Score: 0.010
  27. Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE): A Pilot Study in Alcohol-dependent Women. J Addict Med. 2017 Mar/Apr; 11(2):119-125.
    View in: PubMed
    Score: 0.010
  28. Habituation of distress and craving during treatment as predictors of change in PTSD symptoms and substance use severity. J Consult Clin Psychol. 2017 Mar; 85(3):274-281.
    View in: PubMed
    Score: 0.010
  29. Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N-acetylcysteine treatment (ACCENT) study. Am J Addict. 2017 Mar; 26(2):136-144.
    View in: PubMed
    Score: 0.010
  30. Concurrent treatment of PTSD and alcohol use disorder via telehealth in a female Iraq veteran. Am J Addict. 2017 Mar; 26(2):112-114.
    View in: PubMed
    Score: 0.010
  31. Design and methods for the Better Resiliency Among Veterans and non-Veterans with Omega-3's (BRAVO) study: A double blind, placebo-controlled trial of omega-3 fatty acid supplementation among adult individuals at risk of suicide. Contemp Clin Trials. 2016 Mar; 47:325-33.
    View in: PubMed
    Score: 0.009
  32. Vilazodone for cannabis dependence: A randomized, controlled pilot trial. Am J Addict. 2016 Jan; 25(1):69-75.
    View in: PubMed
    Score: 0.009
  33. Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial. Drug Alcohol Depend. 2015 Nov 01; 156:29-37.
    View in: PubMed
    Score: 0.009
  34. To reduce or abstain? Substance use goals in the treatment of veterans with substance use disorders and comorbid PTSD. Am J Addict. 2015 Oct; 24(7):578-81.
    View in: PubMed
    Score: 0.009
  35. Family composition and symptom severity among Veterans with comorbid PTSD and substance use disorders. Addict Behav. 2015 Nov; 50:117-23.
    View in: PubMed
    Score: 0.009
  36. Men and women from the STRIDE clinical trial: An assessment of stimulant abstinence symptom severity at residential treatment entry. Am J Addict. 2015 Jun; 24(4):336-40.
    View in: PubMed
    Score: 0.009
  37. Cannabis use disorders are comparatively prevalent among nonwhite racial/ethnic groups and adolescents: a national study. J Psychiatr Res. 2014 Mar; 50:26-35.
    View in: PubMed
    Score: 0.008
  38. Substance use disorders and PTSD: an exploratory study of treatment preferences among military veterans. Addict Behav. 2014 Feb; 39(2):369-73.
    View in: PubMed
    Score: 0.008
  39. Alcoholism and liver transplantation: ethical and nursing implications. Perspect Psychiatr Care. 1993 Jan-Mar; 29(1):7-12.
    View in: PubMed
    Score: 0.007
  40. Use of an integrated therapy with prolonged exposure to treat PTSD and comorbid alcohol dependence in an Iraq veteran. Am J Psychiatry. 2012 Jul; 169(7):688-91.
    View in: PubMed
    Score: 0.007
  41. Stimulant abuser groups to engage in 12-step: a multisite trial in the National Institute on Drug Abuse Clinical Trials Network. J Subst Abuse Treat. 2013 Jan; 44(1):103-14.
    View in: PubMed
    Score: 0.007
  42. Helping alliance, retention, and treatment outcomes: a secondary analysis from the NIDA Clinical Trials Network Women and Trauma Study. Subst Use Misuse. 2012 May; 47(6):695-707.
    View in: PubMed
    Score: 0.007
  43. Randomized multi-site trial of the Job Seekers' Workshop in patients with substance use disorders. Drug Alcohol Depend. 2012 Jan 01; 120(1-3):55-64.
    View in: PubMed
    Score: 0.007
  44. A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder. Am J Addict. 2010 Nov-Dec; 19(6):481-9.
    View in: PubMed
    Score: 0.006
  45. Survey of eating disorder symptoms among women in treatment for substance abuse. Am J Addict. 2010 May-Jun; 19(3):245-51.
    View in: PubMed
    Score: 0.006
  46. A placebo-controlled trial of buspirone for the treatment of marijuana dependence. Drug Alcohol Depend. 2009 Nov 01; 105(1-2):132-8.
    View in: PubMed
    Score: 0.006
  47. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009 Aug; 77(4):607-19.
    View in: PubMed
    Score: 0.006
  48. The impact of trauma-focused group therapy upon HIV sexual risk behaviors in the NIDA Clinical Trials Network "Women and trauma" multi-site study. AIDS Behav. 2010 Apr; 14(2):421-30.
    View in: PubMed
    Score: 0.006
  49. Assessment and treatment of co-occurring eating disorders in publicly funded addiction treatment programs. Psychiatr Serv. 2008 Sep; 59(9):1056-9.
    View in: PubMed
    Score: 0.006
  50. Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder. J Clin Psychiatry. 2008 Apr; 69(4):520-5.
    View in: PubMed
    Score: 0.005
  51. Long-term outcomes following decompressive craniectomy for severe head injury. Acta Neurochir Suppl. 2008; 102:29-31.
    View in: PubMed
    Score: 0.005
  52. Effectiveness of abstinence-based incentives: interaction with intake stimulant test results. J Consult Clin Psychol. 2007 Oct; 75(5):805-11.
    View in: PubMed
    Score: 0.005
  53. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study. Arch Gen Psychiatry. 2005 Oct; 62(10):1148-56.
    View in: PubMed
    Score: 0.005
  54. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. Depress Anxiety. 2004; 19(3):190-6.
    View in: PubMed
    Score: 0.004
  55. Comparative profiles of women with PTSD and comorbid cocaine or alcohol dependence. Am J Drug Alcohol Abuse. 2003; 29(1):169-89.
    View in: PubMed
    Score: 0.004
  56. Victimization and PTSD in individuals with substance use disorders: gender and racial differences. Am J Drug Alcohol Abuse. 1996 Feb; 22(1):75-93.
    View in: PubMed
    Score: 0.002
  57. Depression in alcoholic schizophrenic patients. Am J Psychiatry. 1993 Aug; 150(8):1255-6.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.